Valuation: PT Kalbe Farma Tbk.

Capitalization 58,379B 3.59B 3.47B 3.26B 2.89B 5.14B 315B 5.73B 39.22B 14.57B 129B 13.45B 13.18B 542B P/E ratio 2024 *
18.6x
P/E ratio 2025 * 17.1x
Enterprise value 55.24B 3.39M 3.28M 3.09M 2.74M 4.86M 298M 5.42M 37.11M 13.79M 122M 12.73M 12.47M 513M EV / Sales 2024 *
1.69x
EV / Sales 2025 * 1.55x
Free-Float
40.21%
Yield 2024 *
2.62%
Yield 2025 * 2.71%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.69%
1 month-0.78%
3 months-17.86%
6 months-23.56%
Current year-6.99%
More quotes
1 week
1 185.00
Extreme 1185
1 325.00
1 month
1 185.00
Extreme 1185
1 325.00
Current year
1 185.00
Extreme 1185
1 375.00
1 year
1 185.00
Extreme 1185
1 795.00
3 years
1 185.00
Extreme 1185
2 360.00
5 years
830.00
Extreme 830
2 360.00
10 years
830.00
Extreme 830
2 360.00
More quotes
Director TitleAgeSince
Chief Executive Officer 62 2024-05-15
Chief Tech/Sci/R&D Officer - -
General Counsel 42 2005-12-31
Manager TitleAgeSince
Director/Board Member 60 2007-12-31
Chairman 60 2024-05-15
Director/Board Member 53 2015-05-17
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-2.69%0.00%-15.67%-22.87% 3.59B
+0.91%+8.29%+19.39%+266.10% 791B
-0.96%+3.56%-22.72%+91.36% 387B
-0.25%+0.64%-2.10%-10.72% 369B
-1.23%+3.64%+9.05%+32.81% 337B
+0.45%+1.05%+28.50%-16.45% 255B
-1.58%+2.26%+18.09%+40.03% 223B
-0.87%-11.68%-31.06%+13.48% 221B
-0.90%+1.31%+10.07%+20.71% 210B
-1.42%+2.84%-0.44%+21.80% 158B
Average -0.85%+1.68%+1.31%+43.62% 295.36B
Weighted average by Cap. -0.34%+2.24%+5.17%+90.84%
See all sector performances

Financials

2024 *2025 *
Net sales 32,620B 2B 1.94B 1.82B 1.62B 2.87B 176B 3.2B 21.91B 8.14B 72.11B 7.51B 7.36B 303B 35,054B 2.15B 2.08B 1.96B 1.74B 3.08B 189B 3.44B 23.55B 8.75B 77.49B 8.08B 7.91B 326B
Net income 3,167B 195M 188M 177M 157M 279M 17.06B 311M 2.13B 790M 7B 730M 715M 29.42B 3,485B 214M 207M 195M 173M 307M 18.78B 342M 2.34B 870M 7.7B 803M 787M 32.38B
Net Debt -3,136B -193M -186M -175M -155M -276M -16.9B -308M -2.11B -783M -6.93B -722M -708M -29.14B -4,051B -249M -241M -226M -201M -356M -21.83B -397M -2.72B -1.01B -8.95B -933M -914M -37.63B
More financial data * Estimated data
Logo PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Employees
12,924
More about the company
Date Price Change Volume
25-02-07 1,265.00 Rp -2.69% 51,937,400
25-02-06 1,300.00 Rp +7.44% 50,754,500
25-02-05 1,210.00 Rp -3.20% 35,245,500
25-02-04 1,250.00 Rp +4.17% 27,751,900
25-02-03 1,200.00 Rp -5.14% 27,741,200

End-of-day quote INDONESIA S.E., February 06, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
1,265.00IDR
Average target price
1,686.67IDR
Spread / Average Target
+33.33%
Consensus

Quarterly revenue - Rate of surprise